InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

LCTX Stock Earnings: Lineage Cell Therapeutics Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

LCTX stock results show that Lineage Cell Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

XENE Stock Earnings: Xenon Pharmaceuticals Misses EPS for Q2 2024

By InvestorPlace Earnings

XENE stock results show that Xenon Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.

CUTR Stock Earnings: Cutera Misses EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

CUTR stock results show that Cutera missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

CCSI Stock Earnings: Consensus Cloud Solutions Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

CCSI stock results show that Consensus Cloud Solutions beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

DNMR Stock Earnings: Danimer Scientific Beats EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

DNMR stock results show that Danimer Scientific beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Load More